enit

Contattaci Contact Us

Home>Eventi>Moving from umbrella terms to therapeutic features in airway disease: a paradigm shift

VGFM DATA-LAYER

Dettagli dell'Evento:

Moving from umbrella terms to therapeutic features in airway disease: a paradigm shift

Contattaci
Iscrizione:
Gratuita
Data:
18/11/2022 - 19/11/2022
Luogo:
Praga (Repubblica Ceca)
Sede:
CORINTHIA HOTEL PRAGUE
Relatori:
A. G. Mathioudakis , Andrea Bianco, Anke-Hilse Maitland-Van der Zee , C. Crimi, Charlotte Suppli Ulrik , Clive Page, D. Stolz , E. Kocova , Fabio Ricciardolo, Francesca Levi-Schaffer, Joan Soriano , Kian Fan Chung, L. Calzetta , Maria Gabriella Matera, Mario Cazzola, Markus Ollert, Miriam Barrecheguren , Nicola Scichilone, Nicola A. Hanania, Nicolas Roche, Paola Rogliani, Peter J. Barnes, Pierachille Santus, Tododr A. Popov, Vladimir Koblizek
Discipline::
Video & Slide

18 novembre 2022 - Giorno 1

  • Welcome Addresses

    Relatore Markus Ollert

    Data Intervento 18/11/2022 - 08:46

  • Welcome Addresses - The reason for a meeting focused on treatable traits in airway diseases

    Relatore Mario Cazzola

    Data Intervento 18/11/2022 - 09:00

  • Is personalised medicine the key to heterogeneity in airway diseases?

    Relatore Peter J. Barnes

    Data Intervento 18/11/2022 - 09:15

  • Discussion 1

    Relatore -

    Data Intervento 18/11/2022 - 09:30

  • Precision medicine and phenotypes, endotypes, genotypes, regiotypes, and theratypes of allergic airway diseases

    Relatore Anke-Hilse Maitland-Van der Zee

    Data Intervento 18/11/2022 - 09:50

  • Discussion 2

    Relatore -

    Data Intervento 18/11/2022 - 10:25

  • Treatable traits domains and criteria to be considered a trait

    Relatore Fabio Ricciardolo

    Data Intervento 18/11/2022 - 10:40

  • Discussion 3

    Relatore -

    Data Intervento 18/11/2022 - 10:50

  • Treatable traits as a way toward precision medicine of airway diseases

    Relatore Nicola Scichilone

    Data Intervento 18/11/2022 - 11:30

  • Discussion 4

    Relatore -

    Data Intervento 18/11/2022 - 12:05

  • The importance of the U-BIOPRED project in identifying treatable traits in asthma

    Relatore Kian Fan Chung

    Data Intervento 18/11/2022 - 12:15

  • Discussion 5

    Relatore -

    Data Intervento 18/11/2022 - 12:30

  • The search for new biomarkers to identify treatable traits in airway diseases

    Relatore D. Stolz

    Data Intervento 18/11/2022 - 12:40

  • Discussion 6

    Relatore -

    Data Intervento 18/11/2022 - 13:00

  • Precision medicine and treatable traits in asthma – where do we stand?

    Relatore Charlotte Suppli Ulrik

    Data Intervento 18/11/2022 - 14:15

  • Discussion 7

    Relatore -

    Data Intervento 18/11/2022 - 14:35

  • Can we consider T2high and T2low asthma as treatable traits?

    Relatore Nicola A. Hanania

    Data Intervento 18/11/2022 - 14:50

  • Discussion 8

    Relatore -

    Data Intervento 18/11/2022 - 15:05

  • Precision medicine in united airways disease: A treatable traits approach

    Relatore Tododr A. Popov

    Data Intervento 18/11/2022 - 16:20

  • Discussion 9

    Relatore -

    Data Intervento 18/11/2022 - 16:35

  • ACO: Time to move to the treatable traits

    Relatore Joan Soriano

    Data Intervento 18/11/2022 - 16:55

  • Discussion 10

    Relatore -

    Data Intervento 18/11/2022 - 17:15

  • Panel discussion - The Audience 30 Is there a need for a new taxonomy for airway diseases?

    Relatore Peter J. Barnes

    Data Intervento 18/11/2022 - 17:30

19 novembre 2022 - Giorno 2

  • Effectiveness of artificial intelligence for a treatable trait approach in airway diseases

    Relatore L. Calzetta

    Data Intervento 19/11/2022 - 09:00

  • Discussion 11

    Relatore -

    Data Intervento 19/11/2022 - 09:15

  • Alpha-1 antitrypsin deficiency: An underrecognized, treatable trait of airway diseases

    Relatore Miriam Barrecheguren

    Data Intervento 19/11/2022 - 09:35

  • Discussion 12

    Relatore -

    Data Intervento 19/11/2022 - 09:50

  • Are comorbidities treatable traits in airway diseases?

    Relatore Paola Rogliani

    Data Intervento 19/11/2022 - 10:10

  • Discussion 13

    Relatore -

    Data Intervento 19/11/2022 - 10:30

  • Lung microbiome as a treatable trait

    Relatore Andrea Bianco

    Data Intervento 19/11/2022 - 11:15

  • Discussion 14

    Relatore -

    Data Intervento 19/11/2022 - 11:40

  • In search of treatable traits of acute exacerbations of COPD

    Relatore A. G. Mathioudakis

    Data Intervento 19/11/2022 - 11:50

  • Discussion 15

    Relatore -

    Data Intervento 19/11/2022 - 12:15

  • Treatable traits in bronchiectasis

    Relatore C. Crimi

    Data Intervento 19/11/2022 - 12:25

  • Discussion 16

    Relatore -

    Data Intervento 19/11/2022 - 12:45

  • Airway smooth muscle as a treatable trait

    Relatore Maria Gabriella Matera

    Data Intervento 19/11/2022 - 14:00

  • Discussion 17

    Relatore -

    Data Intervento 19/11/2022 - 14:25

  • Eosinophils as a treatable trait

    Relatore Francesca Levi-Schaffer

    Data Intervento 19/11/2022 - 14:35

  • Discussion 18

    Relatore -

    Data Intervento 19/11/2022 - 15:00

  • Current and future targeted therapies for airway diseases

    Relatore Clive Page

    Data Intervento 19/11/2022 - 15:10

  • Diagnosis of stable COPD using the treatable traits concept based on clinical phenotypes

    Relatore Vladimir Koblizek

    Data Intervento 19/11/2022 - 16:15

  • Discussion 19

    Relatore -

    Data Intervento 19/11/2022 - 16:35

  • The use of treatable traits to address COPD complexity and heterogeneity

    Relatore Nicolas Roche

    Data Intervento 19/11/2022 - 16:45

  • Discussion 20

    Relatore -

    Data Intervento 19/11/2022 - 17:10

  • Precision medicine in COPD: from hope to disappointment

    Relatore Pierachille Santus

    Data Intervento 19/11/2022 - 17:15

  • Discussion 21

    Relatore -

    Data Intervento 19/11/2022 - 17:25

  • Treatable traits of airway disease using HRCT

    Relatore E. Kocova

    Data Intervento 19/11/2022 - 17:50

  • Discussion 22

    Relatore -

    Data Intervento 19/11/2022 - 18:15

  • Conclusion and farewell

    Relatore Vladimir Koblizek

    Data Intervento 19/11/2022 - 18:25

Area riservata

Login Annulla
 

APP FONDAZIONE MENARINI

SCOPRI L'APP


Pills of Art Menarini

“Menarini Pills of Art”
Il nuovo progetto multimediale di Menarini legato al mondo dell’arte

VISITA IL SITO


Nuovi Progetti: MINUTI DIGITALE

VISITA IL SITO


Minuti Menarini Online

Abbonati gratis alla rivista cartacea

ABBONATI GRATUITAMENTE


Fondazione Menarini



ISCRIVITI ALLA NEWSLETTER

Ricevi ogni mese le informazioni sulle attività della Fondazione Menarini.

Iscriviti

VGFM DATA-LAYER

Fondazione Menarini
Fondazione Menarini, Centro Direzionale Milanofiori 20089 Rozzano (MI) - Edificio L - Strada 6
Tel. +39 02 55308110 Fax +39 02 55305739 C.F. 94265730484